ACRV
Acrivon Therapeutics, Inc. · Healthcare
President and CEO Peter Blume-Jensen sold $31K of Acrivon Therapeutics, Inc.
Sold$30,969
$2.21Price
14,036Shares
−1%Stake
What ACRV did after the filing
- The stock from Fri, Aug 28 open, $2.16
- −12.0%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Oct 12 close.
Traded Tue, Aug 25. Filed Thu, Aug 27, 4:14 PM ET, after the close. Returns use the Aug 28 open and the Oct 12 close. Not investment advice.